This study demonstrated that G9a/Ehmt2 and GLP/Ehmt1 expression levels were higher in NB tumors of the St4 INSS stage and MYCN-amplified tumors, which are characteristic of a poorer prognosis. This evidence concerns the gene EHMT1 and neuroblastoma.